Cell cycle analysis of the CD133(+) and CD133(-) cells isolated from human colorectal cancer

J Cancer Res Ther. 2012 Jul-Sep;8(3):399-403. doi: 10.4103/0973-1482.103520.

Abstract

Aim: The CD133 antigen has been identified as a putative stem cell marker in colorectal cancer tissues. The aim of this study was to investigate the cell cycle state of CD133(+) and CD133(-) cells, isolated from primary human colorectal tumors.

Materials and methods: After mechanical and enzymatic dissociation of the tumor samples, CD133(+) and CD133(-) subsets were identified and separated by magnetic cell sorting. Flow cytometric analysis was performed to compare the cell cycle of both CD133(+) and CD133(-) cells isolated from primary and liver metastatic cancer cells.

Results: The results indicated that CD133(+) cells isolated from both primary and liver metastatic colorectal cancers were found in higher percentage in the G0/G1 phases. However, the CD133(-) cells isolated from primary colorectal cancers were predominantly found in the S and G2/M phases. Surprisingly, the CD133(-) cells isolated from liver metastatic colorectal cancers were mostly found in the G0/G1 phase.

Conclusion: The present study provides evidence that CD133(+) cells are in a quiescent state in colorectal cancer, representing a mechanism that would at least partially explain chemotherapy resistance and tumor recurrence in post-therapy patients.

MeSH terms

  • AC133 Antigen
  • Aged
  • Antigens, CD / metabolism*
  • Biomarkers, Tumor / metabolism
  • Cell Cycle*
  • Colorectal Neoplasms / drug therapy
  • Colorectal Neoplasms / pathology*
  • Drug Resistance, Neoplasm
  • Female
  • Glycoproteins / metabolism*
  • Humans
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / pathology
  • Liver Neoplasms / secondary*
  • Male
  • Middle Aged
  • Neoplastic Stem Cells*
  • Peptides / metabolism*

Substances

  • AC133 Antigen
  • Antigens, CD
  • Biomarkers, Tumor
  • Glycoproteins
  • PROM1 protein, human
  • Peptides